As of the latest Form 4 filed Jul 1, 2026.
What Rapport Therapeutics, Inc. Common Stock insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 19 most recent filings for RAPP.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2026-06-30 | Gault Cheryl Chief Operating Officer | SSale | −1.00K | $43.15 | $43.2K | Yes (planned) | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | Gault Cheryl, Chief Operating Officer | SSale | −3.31K | $42.17 | $140K | Yes (planned) | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | Gault Cheryl, Chief Operating Officer | SSale | −3.79K | $41.39 | $157K | Yes (planned) | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | Gault Cheryl, Chief Operating Officer | SSale | −1.90K | $40.09 | $76.2K | Yes (planned) | Form 4 ↗ |
| 2026-07-01 | 2026-06-29 | Ceesay Abraham Chief Executive Officer | SSale | −876.00 | $40.34 | $35.3K | Yes (planned) | Form 4 ↗ |
| 2026-07-01 | 2026-06-29 | Ceesay Abraham, Chief Executive Officer | SSale | −7.34K | $39.77 | $292K | Yes (planned) | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Third Rock Ventures V, L.P. 10% owner | SSale | −18.6K | $40.05 | $744K | Yes (planned) | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Third Rock Ventures V, L.P. 10% owner | SSale | −134K | $40.24 | $5.38M | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-17 | Third Rock Ventures V, L.P. 10% owner | SSale | −426K | $40.32 | $17.2M | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-17 | Yeleswaram Krishnaswamy Chief Development Officer | SSale | −20.2K | $39.99 | $809K | Yes (planned) | Form 4 ↗ |
| 2026-04-14 | 2026-04-14 | Yeleswaram Krishnaswamy Chief Development Officer | SSale | −10.2K | $35.08 | $358K | Yes (planned) | Form 4 ↗ |
| 2026-04-14 | 2026-04-13 | Yeleswaram Krishnaswamy, Chief Development Officer | SSale | −9.16K | $34.97 | $321K | Yes (planned) | Form 4 ↗ |
| 2026-04-14 | 2026-04-10 | Yeleswaram Krishnaswamy, Chief Development Officer | SSale | −500.00 | $34.98 | $17.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-09 | 2026-04-08 | Yeleswaram Krishnaswamy Chief Development Officer | SSale | −360.00 | $34.90 | $12.6K | Yes (planned) | Form 4 ↗ |
| 2026-03-31 | 2026-03-30 | Gault Cheryl Chief Operating Officer | SSale | −2.84K | $28.55 | $81.1K | Yes (planned) | Form 4 ↗ |
| 2026-03-31 | 2026-03-30 | Gault Cheryl, Chief Operating Officer | SSale | −7.16K | $28.04 | $201K | Yes (planned) | Form 4 ↗ |
| 2026-03-26 | 2026-03-25 | Yeleswaram Krishnaswamy Chief Development Officer | SSale | −10.1K | $29.99 | $303K | Yes (planned) | Form 4 ↗ |
| 2026-01-22 | 2026-01-20 | Ceesay Abraham Chief Executive Officer | SSale | −5.08K | $26.11 | $133K | Yes (planned) | Form 4 ↗ |
| 2026-01-22 | 2026-01-20 | Ceesay Abraham, Chief Executive Officer | SSale | −5.83K | $26.12 | $152K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also RAPP’s full analysis or the market-wide insider trading feed. The tabs above jump to RAPP’s other SEC data.
Source: SEC Form 4 filings for RAPP, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.